| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Chief Financial Officer | Director | Chief Financial Officer +1 more
5 companies
Bjerkholt Eric serves as a Director at MBOT and has filed Form 4s across 5 companies. Across recent SEC filings that breaks down to 16 buys and 18 sells. Those positions are worth an estimated $5.1M at current prices.
Historically, Bjerkholt Eric's trades have earned a strong insider score of 71/100 across 10 rated trades. Over a 12-month horizon, 57.1% of those trades were profitable, with an average 12-month return of +27.8%.
The biggest single holding is MIRM (~$4.4M) as Chief Financial Officer. The recent filings there lean toward selling, a net 39,283 shares.
| Date | Ticker | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 12, 2024 | CERS Cerus Corp | Director | Sell | 20,000 | $1.79 | $35,700.00 | -11.0% | -16.9% | +22.5% | |
| Mar 27, 2024 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 2,000 | $24.80 | $49,600.00 | +16.7% | +31.9% | +83.4% | |
| Mar 18, 2024 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 2,000 | $25.80 | $51,600.00 | +20.0% | +27.0% | +70.6% | |
| Dec 13, 2023 | CERS Cerus Corp | Director | Buy | 10,000 | $1.62 | $16,200.00 | +7.6% | +18.2% | -1.7% | |
| Sep 11, 2023 | MIRM Mirum Pharmaceuticals, Inc. | Chief Financial Officer | Buy | 10,000 | $29.65 | $296,492.00 | New | +6.1% | +37.3% | |
| Aug 21, 2023 | CERS Cerus Corp | Director | Buy | 10,000 | $1.72 | $17,151.00 | +8.2% | +5.3% | +28.2% | |
| May 31, 2023 | CALC Calcimedica, Inc. | Director | Buy | 255 | $4.14 | $1,055.00 | +7.4% | - | - | |
| May 23, 2023 | CERS Cerus Corp | Director | Buy | 5,000 | $2.00 | $10,000.00 | +6.5% | -12.4% | -0.5% | |
| May 23, 2023 | CALC Calcimedica, Inc. | Director | Buy | 500 | $3.27 | $1,634.00 | +17.1% | - | - | |
| May 19, 2023 | CALC Calcimedica, Inc. | Director | Buy | 200 | $2.65 | $530.00 | +7.3% | - | - |